Zentalis Pharmaceuticals
Latest round
- Series C
Last raised
- Dec 2019
Total raised
- $119M
Investors
- 7
About Zentalis Pharmaceuticals
Based in New York, US, and founded in 2014, Zentalis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company and has operations in both New York and San Diego. Anthony Sun is the Chairman and CEO of the company as of 2021. In 2021, Zentalis granted its majority-owned joint venture licenses for ZN-c5, ZN-c3, and ZN-d5." The company is involved in discovering and developing small-molecule therapeutics targeting fundamental biological pathways of cancers. It uses an Integrated Discovery Engine, or drug discovery engine, to find targets and produce small-molecule novel chemical entities, or NCEs, with characteristics that it believes might result in potentially distinct product profiles. Zentalis’s pipeline includes two lead product candidates: ZN-c5, which is being developed for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer, and ZN-c3, which is being developed for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
Who invested in Zentalis Pharmaceuticals
7 investors across 2 rounds
See all investors in Zentalis Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zentalis Pharmaceuticals
Who invested in Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zentalis Pharmaceuticals raised?
Zentalis Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Zentalis Pharmaceuticals last raise money?
Zentalis Pharmaceuticals's most recent round on record is a Series C, in Dec 2019.
What does Zentalis Pharmaceuticals do?
Based in New York, US, and founded in 2014, Zentalis Pharmaceuticals, Inc.
Where is Zentalis Pharmaceuticals headquartered?
Zentalis Pharmaceuticals is headquartered in New York, US.
Which VCs invest in companies like Zentalis Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zentalis Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Zentalis Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.